TCM

Tekla Capital Management Portfolio holdings

AUM $2.56B
1-Year Est. Return 18.15%
This Quarter Est. Return
1 Year Est. Return
+18.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.85B
AUM Growth
+$177M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
216
New
Increased
Reduced
Closed

Top Buys

1
+$45.7M
2
+$36.7M
3
+$33.8M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$22.1M
5
DXCM icon
DexCom
DXCM
+$20.7M

Top Sells

1
+$44.1M
2
+$40.6M
3
+$39.8M
4
ABBV icon
AbbVie
ABBV
+$27.3M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$22.7M

Sector Composition

1 Healthcare 95.34%
2 Real Estate 2.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
151
$2.37M 0.08%
32,564
152
$2.32M 0.08%
81,867
153
$2.3M 0.08%
51,406
154
$2.29M 0.08%
51,224
155
$2.28M 0.08%
34,979
156
$2.11M 0.07%
101,412
-17,000
157
$2.07M 0.07%
92
158
$2.06M 0.07%
31,286
-5,400
159
$2.06M 0.07%
14,655
160
$1.95M 0.07%
70,662
161
$1.9M 0.07%
77,067
162
$1.78M 0.06%
88,977
-244,425
163
$1.77M 0.06%
10,642
164
$1.7M 0.06%
253,610
+40,300
165
$1.65M 0.06%
+419,005
166
$1.56M 0.05%
233,612
167
$1.56M 0.05%
+26,802
168
$1.51M 0.05%
12,027
169
$1.5M 0.05%
68,150
170
$1.48M 0.05%
13,340
171
$1.47M 0.05%
357,720
172
$1.33M 0.05%
256,398
173
$1.21M 0.04%
+48,089
174
$1.14M 0.04%
10,055
175
$1.08M 0.04%
168,190
5 6
7
8 9